ArticleCancers2022

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.

Marcin Mikołaj Grzybowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.